Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 6,876 shares at $90.03 ($619K) on 2024-02-14, disclosed to the SEC on 2024-02-16.
Scheduled sale ($619k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.03 | 3,050 | $275K | 44.4% |
| 2 | $90.03 | 3,050 | $275K | 44.4% |
| 3 | $90.00 | 776 | $70K | 11.3% |
| Total | $90.03 avg | 6,876 | $619K | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |